Bristol Myers Squibb - 49 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits. The latest closing stock price for Bristol Myers Squibb as of September 23, 2021 is 60.63.
  • The all-time high Bristol Myers Squibb stock closing price was 77.94 on October 28, 1999.
  • The Bristol Myers Squibb 52-week high stock price is 69.75, which is 15% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 56.75, which is 6.4% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 63.73.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 64.5809 61.3800 69.3100 59.3400 60.6300 -2.26%
2020 60.6524 63.3400 67.4300 46.4000 62.0300 -3.37%
2019 50.1838 52.4300 64.1900 42.7700 64.1900 23.49%
2018 57.7859 61.3100 68.9800 48.7600 51.9800 -15.18%
2017 57.5613 59.4500 65.3500 46.8200 61.2800 4.86%
2016 63.1920 67.0300 76.7700 49.2300 58.4400 -15.05%
2015 64.5237 59.5100 70.7100 57.3000 68.7900 16.53%
2014 52.2089 52.2700 61.3000 46.5900 59.0300 11.06%
2013 43.8476 32.7100 53.8400 32.7100 53.1500 63.09%
2012 33.2952 35.0100 36.1500 30.8100 32.5900 -7.52%
2011 28.9302 26.5800 35.2900 24.9700 35.2400 33.08%
2010 25.6371 25.6300 27.9300 22.4400 26.4800 4.87%
2009 21.7191 23.8800 25.9600 17.5100 25.2500 8.60%
2008 21.6487 26.1300 27.0800 17.2600 23.2500 -12.33%
2007 28.8082 26.3800 32.1400 26.1000 26.5200 0.76%
2006 24.1178 23.2400 26.3200 20.2400 26.3200 14.53%
2005 24.2257 25.4300 26.4800 21.0300 22.9800 -10.30%
2004 25.1550 29.3500 30.6400 22.5000 25.6200 -10.42%
2003 25.2421 24.0300 28.8600 21.1300 28.6000 23.54%
2002 30.9320 50.8500 51.3000 20.5500 23.1500 -54.61%
2001 57.3467 71.5000 71.5000 49.0000 51.0000 -31.03%
2000 58.1863 64.4400 73.9400 43.5000 73.9400 15.19%
1999 68.1165 65.2000 77.9400 57.4400 64.1900 -4.05%
1998 54.3212 47.3150 66.9000 44.9050 66.9000 41.39%
1997 38.1206 26.7750 48.9050 26.7750 47.3150 73.63%
1996 23.0023 21.4075 28.9375 19.9375 27.2500 26.92%
1995 17.2268 14.7500 21.5325 14.5325 21.4700 48.38%
1994 13.9728 14.3750 15.1575 12.6575 14.4700 -0.64%
1993 14.6061 16.5950 16.5950 12.7825 14.5625 -13.70%
1992 17.9620 22.0625 22.1875 15.4375 16.8750 -23.51%
1991 19.8315 16.6575 22.0625 15.3450 22.0625 31.72%
1990 14.7655 14.2500 16.9375 12.7500 16.7500 19.64%
1989 12.4070 11.0950 14.2825 11.0000 14.0000 23.76%
1988 10.6511 10.8125 11.5000 9.6250 11.3125 8.70%
1987 11.9236 10.5463 13.7500 9.1250 10.4075 0.77%
1986 9.4609 8.2188 10.9838 7.5475 10.3275 24.71%
1985 7.3259 6.4063 8.4525 6.2188 8.2813 26.48%
1984 5.7989 5.3913 6.5625 5.2188 6.5475 23.98%
1983 4.8534 4.1875 5.9538 3.9375 5.2813 25.65%
1982 3.7147 3.2969 4.5781 3.1956 4.2031 26.58%
1981 3.2716 3.1875 3.6563 2.8831 3.3206 5.46%
1980 2.5446 2.2738 3.2113 1.9219 3.1488 36.16%
1979 2.1596 2.2263 2.3906 1.9531 2.3125 3.50%
1978 2.1048 2.0863 2.4844 1.7656 2.2344 6.30%
1977 2.0358 2.1250 2.2263 1.8047 2.1019 -2.00%
1976 2.2848 2.1641 2.5859 1.9334 2.1447 -0.35%
1975 1.9405 1.5975 2.3006 1.4725 2.1522 37.38%
1974 1.4518 1.4609 1.7541 0.9881 1.5666 8.11%
1973 1.9110 2.1406 2.2306 1.3750 1.4491 -32.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $133.660B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71